Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac...

Area of Science:

• Cardiology
• Pharmacology
• Hypertension Research

Background:

• Hypertension and congestive heart failure (CHF) can lead to adverse cardiac remodeling, affecting myocardial mass and contractility.
• Angiotensin-converting enzyme (ACE) inhibitors are known to reduce blood pressure, potentially mitigating cardiac damage.

Purpose of the Study:

• To investigate the effects of ACE inhibitors on cardiac structure and function across different models of hypertension and heart disease.
• To determine if the beneficial effects of ACE inhibitors are solely due to afterload reduction.

Main Methods:

• Experimental models including renovascular hypertension, DOCA-salt hypertension, spontaneously hypertensive rats (SHR), and myocardial infarction (MI) were used.
• Effects on blood pressure, left ventricular hypertrophy, contractility, fibrosis, and atrial natriuretic factor (ANF) secretion were assessed.
• Normotensive rats were also studied to evaluate age-dependent effects.

Main Results:

• ACE inhibitors normalized blood pressure, cardiac hypertrophy, and hypocontractility in renovascular hypertension.
• In DOCA-salt hypertension, ACE inhibitors had no effect as blood pressure was not reduced.
• In SHR and MI models, ACE inhibitors reversed cardiac hypertrophy, hyperfibrosis, and ANF oversecretion, preventing CHF progression.
• In normal aging, ACE inhibitors prevented age-dependent cardiac hypertrophy.

Conclusions:

• ACE inhibitors exert beneficial effects on the heart, primarily through afterload reduction, in various cardiovascular conditions.
• The efficacy of ACE inhibitors depends on the underlying pathophysiology, particularly the involvement of the renin-angiotensin system.
• ACE inhibitors can reverse cardiac remodeling and prevent heart failure progression in hypertensive and post-infarction states.